临床试验/NCT01796691

NCT01796691已完成不适用

Optimized Antiplatelet Therapy With Aspirin and Clopidogrel Improves Mortality Compared to Standard Treatment.

Ruhr University of Bochum1 个研究点分布在 1 个国家目标入组 600 人开始时间: 2009年1月最近更新: 2013年2月26日

适应症

试验速览

阶段: 不适用
状态: 已完成
发起方
入组人数: 600
试验地点: 1
主要终点: Adverse cardiac events (MACE: mortality,rehospitalisation,myocardial infarction)

研究概览研究设计入排标准结局指标研究者研究点记录与标识符相似试验

研究概览

简要总结

Comparing standard treatment versus optimized antiplatelet therapy and outcomes measures.

详细描述

The study is aimed to evaluate if optimized antiplatelet treatment using a test and treat algorithm (with whole blood aggregometry) is able to improve clinical outcome of patients compared to standard treatment without platelet function testing.

研究设计

研究类型: Observational
观察模型: Case Control
时间视角: Retrospective

入排标准

年龄范围: 18 Years 至 —（Adult, Older Adult）
性别: All
接受健康志愿者: 否

入选标准

•coronary stent implantation

排除标准

•no consent

结局指标

主要结局

Adverse cardiac events (MACE: mortality,rehospitalisation,myocardial infarction)

时间窗: Follow up for up to 12 months (retrospective analysis)

MACE-rate

次要结局

未报告次要终点

研究者

发起方

Ruhr University of Bochum

申办方类型

Other

责任方

Principal Investigator

主要研究者

Horst Neubauer

PHD, MD

Ruhr University of Bochum

研究点 (1)

Loading locations...

相似试验

Unknown

不适用

Effect of Different Anti-platelet Strategies on the Long-term Outcome After Sirolimus Drug-eluting Stent ImplantationCoronary Artery Disease

NCT01233167Sir Run Run Shaw Hospital5,232

已完成

不适用

Optimizing Aspirin and Clopidogrel Therapy (BOchum CLopidogrel and Aspirin Plan)Coronary Artery Disease

NCT01212302Ruhr University of Bochum500

已完成

4 期

Comparison of Effect & Safety of Clopidogrel Napadisilate With Clopidogrel Bisulfate in Coronary Artery Disease PatientsCoronary Artery Disease (CAD)

NCT01830491Hanmi Pharmaceutical Company Limited162

已完成

4 期

Optimal Duration of Dual Antiplatelet Therapy After Drug-eluting Stent ImplantationStent ThrombosisCoronary Artery DiseaseMyocardial Ischemia

NCT00822536Assistance Publique - Hôpitaux de Paris1,798

尚未招募

4 期

Comparison of the Antiplatelet Efficacy of Aspirin Combined With Clopidogrel and Aspirin Combined With Half-dose Ticagrelor in Patients With Unruptured Intracranial Aneurysms With Normal CYP2C19 Metabolizer PhenotypeIntracranial AneurysmsAntiplatelet Drugs

NCT06486363The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School196